{"id":48439,"date":"2022-09-15T16:02:29","date_gmt":"2022-09-15T14:02:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/"},"modified":"2022-09-15T16:02:29","modified_gmt":"2022-09-15T14:02:29","slug":"cardiology-compensation-and-new-patient-visits-rebound-survey-finds","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/","title":{"rendered":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>10<\/i><i><sup>th<\/sup><\/i><i> annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends<\/i>\n<\/p>\n<p>NEPTUNE BEACH, Fla.&#8211;(BUSINESS WIRE)&#8211;MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10<sup>th<\/sup> annual <i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbit.ly%2F3d62rAV%3Futm_source%3DNews%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2022_Comp_Survey%26utm_id%3D2022%2BComp%2BSurvey&amp;esheet=52906048&amp;newsitemid=20220915005751&amp;lan=en-US&amp;anchor=Cardiovascular+Provider+Compensation+and+Production+Survey+Report&amp;index=1&amp;md5=f3f58ed2c31f08f17a6aeebf54268f87\" rel=\"nofollow noopener\" shape=\"rect\">Cardiovascular Provider Compensation and Production Survey Report<\/a><\/i> that includes data from the largest number of providers since its debut. The report features a special section on 10-year trends in addition to year-over-year comparisons.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/5\/ACC_MedAxiom_Logo-2022-STACKED.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg\"><\/a><\/p>\n<p>\n2022 Report Highlights:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nOverall median cardiology compensation returned to pre-pandemic levels, but not as high as 2019\n<\/li>\n<li>\nCompensation for cardiologists in private programs is only 3% lower than cardiologists in integrated programs; compared to a 20% gap only four years ago\n<\/li>\n<li>\nNew patient visits climbed in 2021, surpassing pre-pandemic levels\n<\/li>\n<li>\nProcedure volumes rebounded for all three advanced imaging modalities and cardiac catheterizations\n<\/li>\n<li>\nEmployed\/integrated continues to be the overwhelmingly dominant ownership model (nearly nine out of 10 programs)\n<\/li>\n<\/ul>\n<p>\n\u201cOver the last few years, the COVID pandemic and subsequent \u2018Great Resignation\u2019 have made a complex healthcare environment even more volatile. To thrive in the new normal, cardiovascular programs need access to accurate and actionable data, expert analyses and robust reports,\u201d said Jerry Blackwell, MD, MBA, FACC, MedAxiom\u2019s president and CEO. \u201cMedAxiom\u2019s 10<sup>th<\/sup> annual report includes year-over-year comparisons that provide insights into where cardiovascular programs have returned to, or even exceeded, pre-pandemic levels and where they are still lagging.\u201d\n<\/p>\n<p>\nData for the 2022 report were collected from nearly 200 cardiovascular programs representing almost 5,700 total cardiovascular providers.\n<\/p>\n<p>\n\u201cThe past decade has brought many interesting and revealing changes to the practice of cardiology. From procedure shifts and the mix of cardiologists to the production and compensation alterations that result, it has been a dynamic 10 years. While no one can predict the future, the beauty of surveys is their ability to measure the past. MedAxiom is looking forward to the next 10 years of cardiology surveys to provide the community with invaluable data and peer comparisons,\u201d noted Joel Sauer, MBA, report co-author and MedAxiom\u2019s executive vice president of Consulting.\n<\/p>\n<p>\n<b>The full report is <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbit.ly%2F3d62rAV%3Futm_source%3DNews%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2022_Comp_Survey%26utm_id%3D2022%2BComp%2BSurvey&amp;esheet=52906048&amp;newsitemid=20220915005751&amp;lan=en-US&amp;anchor=available+here&amp;index=2&amp;md5=ed5042efbd3887976f089c18133877c1\" rel=\"nofollow noopener\" shape=\"rect\">available here<\/a>.<\/b>\n<\/p>\n<p>\n<b>About MedAxiom<\/b>\n<\/p>\n<p>\nMedAxiom, an ACC Company, is the cardiovascular community\u2019s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of 450+ cardiovascular organization members, thousands of administrators, clinicians and coders and 40+ industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For additional information, visit <i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.medaxiom.com%2F&amp;esheet=52906048&amp;newsitemid=20220915005751&amp;lan=en-US&amp;anchor=MedAxiom.com&amp;index=3&amp;md5=cafdc57562f4a1b26e3760cd28258466\" rel=\"nofollow noopener\" shape=\"rect\">MedAxiom.com<\/a><\/i><i>.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKim Kaylor<br \/>\n<br \/>904-524-4703<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;k&#107;&#x61;&#x79;l&#111;&#x72;&#64;&#109;&#x65;&#x64;a&#120;&#x69;&#x6f;m&#46;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#107;a&#x79;&#x6c;&#111;r&#x40;&#x6d;&#101;d&#x61;&#120;i&#x6f;&#x6d;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>10th annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends NEPTUNE BEACH, Fla.&#8211;(BUSINESS WIRE)&#8211;MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10th annual Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48439","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"10th annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends NEPTUNE BEACH, Fla.&#8211;(BUSINESS WIRE)&#8211;MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10th annual Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T14:02:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cardiology Compensation and New Patient Visits Rebound, Survey Finds\",\"datePublished\":\"2022-09-15T14:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/\"},\"wordCount\":427,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005751\\\/en\\\/1573154\\\/21\\\/ACC_MedAxiom_Logo-2022-STACKED.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/\",\"name\":\"Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005751\\\/en\\\/1573154\\\/21\\\/ACC_MedAxiom_Logo-2022-STACKED.jpg\",\"datePublished\":\"2022-09-15T14:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005751\\\/en\\\/1573154\\\/21\\\/ACC_MedAxiom_Logo-2022-STACKED.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005751\\\/en\\\/1573154\\\/21\\\/ACC_MedAxiom_Logo-2022-STACKED.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiology Compensation and New Patient Visits Rebound, Survey Finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/","og_locale":"en_US","og_type":"article","og_title":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend","og_description":"10th annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends NEPTUNE BEACH, Fla.&#8211;(BUSINESS WIRE)&#8211;MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10th annual Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-15T14:02:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds","datePublished":"2022-09-15T14:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/"},"wordCount":427,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/","url":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/","name":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg","datePublished":"2022-09-15T14:02:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220915005751\/en\/1573154\/21\/ACC_MedAxiom_Logo-2022-STACKED.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cardiology-compensation-and-new-patient-visits-rebound-survey-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cardiology Compensation and New Patient Visits Rebound, Survey Finds"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48439"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48439\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}